Mary Ann Liebert, Inc

Mary Ann Liebert Inc. was founded in 1980 by Mary Ann Liebert in New Rochelle, NY. The company publishes peer-reviewed journals, books and trade magazines in a variety of fields. A sample of journals, include Genetic Engineering & Biotechnology News, Human Gene Therapy and Women's Health. BioConferences International Inc. is a subsidiary of Mary Ann Liebert Inc. This company's focus is to organize symposiums and conferences in Biotechnology, Women's Health, Alternative Medicine, Law and more.

Address
140 Huguenot Street, 3rd Floor New Rochelle, NY 10801-5215 Phone: 914- 740-2100
Website
http://www.liebertpub.com/
Wikipedia
http://en.wikipedia.org/wiki/Mary_Ann_Liebert,_Inc.

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Psychology & Psychiatry

Social media can identify fathers at risk of postpartum depression

Fathers' prepartum social media posts can predict their risk of postpartum depression. A predictive model based on machine learning is described in the peer-reviewed journal Cyberpsychology, Behavior, and Social Networking. ...

Genetics

Concern following gene therapy adverse events

The Editor-in-Chief of Human Gene Therapy, the first journal devoted to the field of gene therapy, and one of the world's leading experts on gene therapy have co-authored a new editorial, Moving Forward After Two Deaths in ...

Oncology & Cancer

New protocol on breast cancer and breastfeeding

Managing women with breast cancer who are breastfeeding is a complex issue. The Academy of Breastfeeding Medicine presents new recommendations in the peer-reviewed journal Breastfeeding Medicine.

Diseases, Conditions, Syndromes

Beating COVID-19 through genomic research

Next-generation sequencing of the COVID-19 virus is providing powerful metagenomic data, which, combined with clinical data, will inform the search for effective treatments, as reported in the peer-reviewed journal Pediatric ...

Diseases, Conditions, Syndromes

Pregnant and lactating women with COVID-19: Scant clinical research

Pregnant and breastfeeding women have been excluded from clinical trials of drugs to treat COVID-19, and as result, there is no safety data to inform clinical decisions. Such drugs include remdesivir according to a new article ...

Obstetrics & gynaecology

Earlier gestational diabetes diagnosis, less weight gain

A new study has shown that initiating screening for gestational diabetes in high-risk women in the first trimester of pregnancy instead of the second trimester, allowing for treatment to start earlier, can help optimize gestational ...

page 1 from 93